Brief: Nexstim's NBS System 6 Gains FDA Clearance
March 23 (Reuters) - Nexstim Oyj NXTMH.HE: NEXSTIM'S NBS SYSTEM 6 GAINS FDA CLEARANCE FOR TREATMENT OF ADOLESCENT DEPRESSION Further company coverage: NXTMH.HE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Nexstim Oyj
See all newsBrief: Nexstim Receives Order For NBS 6 System From Finnish Hospital
Brief: Nexstim Gets Order for NBS 6 System From European Hospital
Brief: US University Customer Purchases Nexstim NBS 6 For Research Purposes
Brief: Nexstim Gets NBS 6 System Order For European Hospital
Brief: Nexstim Gets Order From New U.S. Customer